Cabaletta Bio: Do You Buy With The Insiders? [Seeking Alpha]
Cabaletta Bio, Inc. (CABA)
Company Research
Source: Seeking Alpha
Recent insider share purchases have apparently bolstered confidence in CABA's prospects following key data releases since October. At Q3 2025, CABA reported $60.2 million in cash and $99.7 million in short-term investments, supporting ongoing development. Strengths include promising pipeline updates, while risks remain around cash runway and clinical progress. Morsa Images/DigitalVision via Getty Images Topline Summary and Update I've maintained a steady, cautious optimism for Cabaletta Bio ( CABA ) as they have tried to march an engineered cell therapy through the clinical trial pipeline in the field of This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relat
Show less
Read more
Impact Snapshot
Event Time:
CABA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CABA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CABA alerts
High impacting Cabaletta Bio, Inc. news events
Weekly update
A roundup of the hottest topics
CABA
News
- What Makes Cabaletta Bio, Inc. (CABA) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]Yahoo! Finance
- Cabaletta Bio Announces 2026 Strategic Priorities [Yahoo! Finance]Yahoo! Finance
- Cabaletta Bio Announces 2026 Strategic PrioritiesGlobeNewswire
- IND Amendment Clearance Obtained for Clinical Manufacturing of Rese-Cel from Cabaletta Bio Using Cellares' Automated PlatformsBusiness Wire
- Is Cabaletta Bio (NASDAQ:CABA) In A Good Position To Invest In Growth? [Yahoo! Finance]Yahoo! Finance
CABA
Earnings
- 11/10/25 - Beat
CABA
Sec Filings
- 1/21/26 - Form 4
- 1/21/26 - Form 4
- 1/21/26 - Form 4
- CABA's page on the SEC website